Reliability, validity, and responsiveness of the impact of weight on self-perceptions questionnaire (IW-SP) in individuals with type 2 diabetes and obesity

Diabetes Technology and Therapeutics

Volumn 17, Issue 3, 2015, Pages 210-214

  Hayes, Risa P ^a   Delozier, Amy M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONVERGENT VALIDITY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DISCRIMINANT VALIDITY; EFFECT SIZE; FEMALE; HUMAN; IMPACT OF WEIGHT ON SELF PERCEPTION QUESTIONNAIRE; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; TEST RETEST RELIABILITY; UNITED STATES; VALIDITY; WEIGHT REDUCTION; COMPLICATION; DIABETES MELLITUS, TYPE 2; EVALUATION STUDY; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; PSYCHOMETRY; REPRODUCIBILITY; SELF CONCEPT; STANDARDS; WEIGHT LOSS PROGRAM;

ADULT; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SELF CONCEPT; SURVEYS AND QUESTIONNAIRES; UNITED STATES; WEIGHT REDUCTION PROGRAMS;

EID: 84923858619     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0142     Document Type: Article

References (19)

1. Hayes RP, Nelson DR, Meldahl ML, Curtis BH. Ability to perform daily physical activities in individuals with type 2 diabetes and moderate obesity: a preliminary validation of the Impact of Weight on Activities of Daily Living Questionnaire. Diabetes Technol Ther 2011; 13: 705-712
2. Hayes RP, Schultz EM, Naegeli AN, Curtis BH. Test-retest, responsiveness, and minimal important change of the Ability to Perform Physical Activities of Daily Living Questionnaire in individuals with type 2 diabetes and obesity. Diabetes Technol Ther 2012; 14: 1118-1125
3. Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes. JAMA 2007; 298: 194-206
4. Vilsboll T, Christensen M, Junker AE, Knop FK, Gluud LL. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-Analyses of randomised controlled trials. BMJ 2012; 344: d7771
5. Curtis B, Hayes RP, Fehnel S, Zografos L. Assessing the effect of weight and weight loss in obese persons with type 2 diabetes. Diabetes Metab Syndr Obes 2008; 1: 13-23
6. Ware JE. SF-36- Health Survey Update. www.sf-36.org/tools/SF36.shtml (accessed January 13, 2012
7. Niero M, Martin M, Finger T, Lucas R, Mear I, Wild D, Glauda L, Patrick DL A new approach to multicultural item generation in the development of two obesity-specific measures: the Obesity and Weight Loss Quality of Life (OWLQOL) questionnaire and the Weight-Related Symptom Measure (WRSM). Clin Ther 2002; 24: 690-700
8. Patrick DL, Bushnell DM, Rothman M. Performance of two self-report measures for evaluating obesity and weight loss. Obes Res 2004; 12: 48-57
9. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1996; 1: 30-46
10. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334
11. de Leiva A. What are the benefits of moderate weight loss? Exp Clin Endocrinol Diabetes 1998; 106(Suppl 2): 10-13
12. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry: Developing Products for Weight Management. 2007. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071612.pdf (accessed March 25, 2012
13. Kolotkin RL, Norquist JM, Crosby RD, Suryanwanshi S, Teixeira PJ, Heymsfield SB, Erondu N, Nguyen AM. Oneyear health-related quality of life outcomes in weight loss trial participants: comparison of three measures. Health Qual Life Outcomes 2009; 7: 53.
14. Rippe JM, Price JM, Hess SA, Kline G, DeMers KA, Damitz S, Kreidieh S, Freedsoni P. Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program. Obes Res 1998; 6: 208-218
15. Fontaine KR, Barofsky I, Bartlett SJ, Franckowiak SC, Andersen RE. Weight loss and health-related quality of life: results at 1-year follow-up. Eat Behav 2004; 5: 85-88
16. Wouters EJ, Van Nunen AM, Geenen R, Kolotkin RL, Vingerhoets AJ. Effects of aquajogging in obese adults: a pilot study. J Obes 2010; 2010: 231074
17. Desiderio J, Trastulli S, Scalercio V, Mirri E, Grandone I, Cirocchi R, Penzo J, Santoro A, Redler A, Boselli C, Noya G, Fatati G, Parisi A. Effects of laparoscopic sleeve gastrectomy in patients with morbid obesity and metabolic disorders. Diabetes Technol Ther 2013; 15: 1004-1009
18. Desiderio J, Trastulli S, Scalercio V, Cirocchi R, Carloni G, Moriconi E, Boselli C, Noya G, Parisi A. Laparoscopic sleeve gastrectomy and medical management for the treatment of type 2 diabetes mellitus in non-morbidly obese patients: a single-center experience. Diabetes Technol Ther 2013; 15: 281-288
19. Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH), Food and Drug Administration, U.S. Department of Health and Human Services: Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf (accessed March 25, 2012